Nuzenio

Maravai Lifesciences

Maravai Lifesciences news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Maravai LifeSciences (MRVI) Stock Faces Losses Despite Margin Recovery - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:06:31 GMT Maravai LifeSciences (MRVI) Releases Q2 2026 Earnings: Revenue Beats Estimates and Loss Narrows - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:39:00 GMT Deutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 19:27:32 GMT MRVI Maintains Overweight Rating by Wells Fargo -- Price Target Raised to $6.50 - GuruFocusGuruFocus · Fri, 07 Aug 2026 16:47:42 GMT Wells Fargo & Company Issues Positive Forecast for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 15:44:53 GMT Maravai LifeSciences posts investor presentation on mRNA, gene editing, cell and gene therapy tools platform - BitgetBitget · Fri, 07 Aug 2026 15:28:12 GMT Maravai LifeSciences Holdings, Inc. (MRVI) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 14:10:44 GMT Maravai LifeSciences Holdings, Inc. (MRVI) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 08:21:57 GMT

Timeline

Sat, 08 Aug 2026 07:06:31 GMTMaravai LifeSciences (MRVI) Stock Faces Losses Despite Margin Recovery - simplywall.st

Fri, 07 Aug 2026 20:39:00 GMTMaravai LifeSciences (MRVI) Releases Q2 2026 Earnings: Revenue Beats Estimates and Loss Narrows - Quiver Quantitative

Fri, 07 Aug 2026 19:27:32 GMTDeutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating - Moomoo

Fri, 07 Aug 2026 16:47:42 GMTMRVI Maintains Overweight Rating by Wells Fargo -- Price Target Raised to $6.50 - GuruFocus

Fri, 07 Aug 2026 15:44:53 GMTWells Fargo & Company Issues Positive Forecast for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat

Fri, 07 Aug 2026 15:28:12 GMTMaravai LifeSciences posts investor presentation on mRNA, gene editing, cell and gene therapy tools platform - Bitget

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

Connected entities

MRVI21 live mentions Maravai LifeSciences Holdings10 live mentions Inc10 live mentions Results8 live mentions NASDAQ6 live mentions MAR6 live mentions Earnings Report6 live mentions Call6 live mentions Stock Price5 live mentions Can4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Maravai Lifesciences.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.